Boundless Bio, Inc.

8-K Entered a material agreement; Exit or disposal costs; Unregistered sale of equity; Change in control; Director or officer change; Regulation FD disclosure; Other events Jun 23, 2026 8-K Shareholder vote results Jun 17, 2026 10-Q Quarter ended 2026-03-31 May 8, 2026 8-K Results of operations (earnings release) May 8, 2026 8-K Terminated a material agreement; Took on a direct financial obligation Apr 13, 2026 10-K Fiscal year ended 2025-12-31 Mar 9, 2026 8-K Results of operations (earnings release); Director or officer change Mar 9, 2026 10-Q Quarter ended 2025-09-30 Nov 5, 2025 8-K Results of operations (earnings release) Nov 5, 2025 10-Q Quarter ended 2025-06-30 Aug 5, 2025 8-K Results of operations (earnings release) Aug 5, 2025 8-K Shareholder vote results Jun 23, 2025 8-K Exit or disposal costs; Other events May 23, 2025 10-Q Quarter ended 2025-03-31 May 9, 2025 8-K Results of operations (earnings release) May 9, 2025 8-K Entered a material agreement Apr 1, 2025 10-K Fiscal year ended 2024-12-31 Mar 27, 2025 8-K Results of operations (earnings release) Mar 27, 2025 8-K Director or officer change; Regulation FD disclosure; Other events Dec 12, 2024 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Results of operations (earnings release) Nov 7, 2024 8-K Director or officer change Oct 15, 2024 8-K Director or officer change Aug 20, 2024 8-K Results of operations (earnings release) Aug 12, 2024 10-Q Quarter ended 2024-06-30 Aug 12, 2024 10-Q Quarter ended 2024-03-31 May 13, 2024 8-K Results of operations (earnings release); Regulation FD disclosure May 13, 2024 8-K Amended charter or bylaws; Other events Apr 2, 2024 4 Jul 21, 2026 4 Jul 16, 2026 4 Jul 13, 2026 4 Jul 8, 2026 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Jul 6, 2026 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Jul 6, 2026 4 Jul 2, 2026 SCHEDULE 13G Jun 29, 2026 4 Jun 29, 2026 3 Jun 29, 2026 425 Jun 23, 2026 4 Jun 15, 2026